Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksAllergy Thera. Share News (AGY)

Share Price Information for Allergy Thera. (AGY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.975
Bid: 2.85
Ask: 3.10
Change: 0.10 (3.48%)
Spread: 0.25 (8.772%)
Open: 2.875
High: 2.975
Low: 2.875
Prev. Close: 2.875
AGY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Shareholder Meetings Calendar - Next 7 Days

Tue, 01st Dec 2020 16:06

Wednesday 2 December 
Kingswood Holdings LtdAGM
Target Healthcare REIT PLCAGM
JPMorgan Global Emerging Markets Income Trust PLCAGM
Gunsynd PLCGM re share placing
Rambler Metals & Mining PLCAGM
Thursday 3 December 
Nanoco Group PLCAGM
Marwyn Value Investors LtdAGM adjourned from 17 November
CQS New City High Yield Fund LtdAGM
B&M European Value Retail SAEGM re changes related to Brexit
MJ Gleeson PLCAGM
Ormonde Mining PLCAGM
Ferguson PLCAGM
Ceiba Investments LtdEGM re issue of shares at 104.3p each
STV Group PLCGM re bonus issue
Friday 4 December 
VinaCapital Vietnam Opportunity Fund LtdAGM
Auctus Growth PLCGM re purchase of HeiQ Materials AG
KKV Secured Loan Fund LtdEGM re investment policy, cash return, wind-down
Associated British Foods PLCAGM
Abcam PLCAGM
Hammerson PLCGM re scrip dividend
Warehouse REIT PLCGM re Greenstone acquisition
Monday 7 December 
Gore Street Energy Storage Fund PLCGM re placing programme
Renalytix AI PLCAGM
Inspecs Group PLCGM re share placing
Gabelli Value Plus+ Trust PLCGM re continuation resolution
McCarthy & Stone PLCGM re acquisition by Bidco
Tuesday 8 December 
Worsley Investors LtdAGM
Gattaca PLCAGM
Volta Finance LtdAGM
Allergy Therapeutics PLCAGM
Greatland Gold PLCAGM
Haydale Graphene Industries PLCAGM
Henderson International Income Trust PLCAGM
  
Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
26 Sep 2016 09:46

Numis reiterates 'buy' on Allergy Therapeutics after full year results

(ShareCast News) - Numis reiterated a 'buy' rating and target price of 37p on Allergy Therapeutics on Monday after the company reported its full year results. Allergy reported a 19% increase in revenue at constant currency to £51.5m in the year ended 30 June as it grew market share in its main Europ

Read more
13 Jul 2016 08:43

Allergy Therapeutics Expects Revenue Rise Despite Euro Weakening

Read more
8 Jul 2016 14:02

Allergy Therapeutics sees good results from Acarovac Plus

(ShareCast News) - Specialty pharmaceutical company Allergy Therapeutics published a one-year follow up study of patients using Acarovac Plus on Friday, in the peer-review journal Immunotherapy. The AIM-traded firm's Acarovac Plus product was described as a microcrystalline tyrosine-adsorbed, house

Read more
8 Jul 2016 07:26

Allergy Therapeutics Welcomes Positive Follow-Up Results For Acarovac

Read more
27 Jun 2016 09:51

WINNERS & LOSERS SUMMARY: easyJet And Foxtons In Post-Brexit Warnings

Read more
27 Jun 2016 09:06

Allergy Therapeutics Sees Delayed US Market Launch For GrassMATAMPL

Read more
10 Jun 2016 07:41

Allergy Therapeutics Appoints Skyepharma's Wykeman As Finance Director

Read more
9 May 2016 06:57

Allergy Therapeutics Gets Positive Birch Pollen Treatment Results

Read more
5 Apr 2016 08:12

NetScientic Poaches New Finance Boss From Allergy Therapeutics

Read more
17 Mar 2016 09:08

Allergy Therapeutics Finance Director Ian Postlethwaite Resigns

Read more
10 Mar 2016 09:33

BROKER RATINGS SUMMARY: Jefferies Starts Metro Bank With Buy Rating

Read more
8 Mar 2016 10:59

Allergy Therapeutics Profit Drops On Higher Costs As Revenue Edges Up

Read more
18 Feb 2016 08:08

Allergy Therapeutics Completes Enrolment For Grass Pollen Drug Study

Read more
13 Jan 2016 09:38

Allergy Therapeutics Revenue Up In First Half, Full Year Seen In Line

Read more
7 Dec 2015 07:54

Allergy Therapeutics Begins US Phase II Study Of Grass Allergy Vaccine

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.